{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:44:46Z","timestamp":1791305086504,"version":"4.3.1"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adult T-cell leukemia (ATL) is a lymphoproliferative malignancy associated with human T-cell lymphotropic virus type 1 (HTLV-1) infection. Recently, it has been shown that allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for ATL, and that HTLV-1 Tax-specific CD8+ cytotoxic T cells (CTL) contribute to the graft-versus-ATL effect. In the present study, we, for the first time, analyzed the T-cell receptor (TCR) repertoire of isolated Tax301\u2013309 (SFHSLHLLF)-specific CTLs in HLA-A*2402+ ATL patients before and after allo-HSCT by single-cell reverse transcription-PCR. The Tax301\u2013309-specific CTLs in bone marrow and peripheral blood showed highly restricted oligoclonal diversity. In addition, a unique conserved amino acid motif of \u201cP-D\/P-R\u201d in TCR-\u03b2 complementarity-determining region 3 in either BV7- or BV18-expressing CTLs was observed not only in all of the samples from ATL patients, but also in samples from the same patient before and after HSCT. Furthermore, the P-D\/P-R motif\u2013bearing CTL clones established from peripheral blood samples after HSCT exhibited strong killing activity against the HTLV-1\u2013infected T cells of the patient. CTL clones were not established in vitro from samples prior to allo-HSCT. In addition, CTL clones with a strong killing activity were enriched in vivo after HSCT in the patient. Hence, Tax301\u2013309-specific CTLs in ATL patients might have a preference for TCR construction and induce strong immune responses against the HTLV-1\u2013infected T cells of patients, which contribute to the graft-versus-ATL effects after allo-HSCT. However, further analyses with a larger number of patients and more frequent sampling after allo-HSCT is required to confirm these findings. Cancer Res; 70(15); 6181\u201392. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-0678","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T02:44:57Z","timestamp":1279680297000},"page":"6181-6192","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Single-Cell Analysis of T-Cell Receptor Repertoire of HTLV-1 Tax-Specific Cytotoxic T Cells in Allogeneic Transplant Recipients with Adult T-Cell Leukemia\/Lymphoma"],"prefix":"10.1158","volume":"70","author":[{"given":"Yukie","family":"Tanaka","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Sato","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiriko","family":"Terasako","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Okuda","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Oshima","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Tanihara","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Nishida","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nakatsura","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; and 3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"2022061701372049500_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"2022061701372049500_bib2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701372049500_bib3","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701372049500_bib4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701372049500_bib5","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/jvi.66.5.2928-2933.1992","article-title":"Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells","volume":"66","author":"Kannagi","year":"1992","journal-title":"J Virol"},{"key":"2022061701372049500_bib6","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/jvi.70.8.4919-4926.1996","article-title":"Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response","volume":"70","author":"Pique","year":"1996","journal-title":"J Virol"},{"key":"2022061701372049500_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"2022061701372049500_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.2003.04054.x","article-title":"Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia\/lymphoma","volume":"120","author":"Kami","year":"2003","journal-title":"Br J Haematol"},{"key":"2022061701372049500_bib9","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"key":"2022061701372049500_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbmt.2008.04.014","article-title":"A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia\/lymphoma (ATL): clinical impact of graft-versus-leukemia\/lymphoma effect","volume":"14","author":"Shiratori","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022061701372049500_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbmt.2006.09.002","article-title":"Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia\/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program","volume":"13","author":"Kato","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022061701372049500_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/0008-5472.CAN-03-1452","article-title":"Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation","volume":"64","author":"Harashima","year":"2004","journal-title":"Cancer Res"},{"key":"2022061701372049500_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/088922201300343735","article-title":"HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes","volume":"17","author":"Yashiki","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022061701372049500_bib14","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1128\/JVI.79.15.10088-10092.2005","article-title":"Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation","volume":"79","author":"Harashima","year":"2005","journal-title":"J Virol"},{"key":"2022061701372049500_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1084\/jem.180.3.831","article-title":"Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V\u03b2 CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"180","author":"Hara","year":"1994","journal-title":"J Exp Med"},{"key":"2022061701372049500_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-5728(95)00129-8","article-title":"Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease","volume":"63","author":"Elovaara","year":"1995","journal-title":"J Neuroimmunol"},{"key":"2022061701372049500_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1128\/jvi.70.2.843-851.1996","article-title":"Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion","volume":"70","author":"Utz","year":"1996","journal-title":"J Virol"},{"key":"2022061701372049500_bib18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.162.3.1765","article-title":"Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2\/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy","volume":"162","author":"Bieganowska","year":"1999","journal-title":"J Immunol"},{"key":"2022061701372049500_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/319264","article-title":"Human T cell leukemia virus type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy\/tropical spastic paraparesis than in asymptomatic carriers","volume":"183","author":"Ureta-Vidal","year":"2001","journal-title":"J Infect Dis"},{"key":"2022061701372049500_bib20","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1128\/JVI.75.20.9836-9843.2001","article-title":"Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19\/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex\/peptide\/TCR crystal structure","volume":"75","author":"Bourcier","year":"2001","journal-title":"J Virol"},{"key":"2022061701372049500_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/JVI.75.2.1065-1071.2001","article-title":"In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes","volume":"75","author":"Saito","year":"2001","journal-title":"J Virol"},{"key":"2022061701372049500_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1086\/344315","article-title":"Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis","volume":"186","author":"Saito","year":"2002","journal-title":"J Infect Dis"},{"key":"2022061701372049500_bib23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10067-004-0901-z","article-title":"HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy","volume":"23","author":"Kato","year":"2004","journal-title":"Clin Rheumatol"},{"key":"2022061701372049500_bib24","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.4049\/jimmunol.161.12.6674","article-title":"Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals","volume":"161","author":"Eiraku","year":"1998","journal-title":"J Immunol"},{"key":"2022061701372049500_bib25","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood-2005-09-3902","article-title":"Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome","volume":"108","author":"Wlodarski","year":"2006","journal-title":"Blood"},{"key":"2022061701372049500_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.179.4.1261","article-title":"Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire","volume":"179","author":"Kalams","year":"1994","journal-title":"J Exp Med"},{"key":"2022061701372049500_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1074-7613(00)80546-4","article-title":"Two human T cell receptors bind in a similar diagonal mode to the HLA-A2\/Tax peptide complex using different TCR amino acids","volume":"8","author":"Ding","year":"1998","journal-title":"Immunity"},{"key":"2022061701372049500_bib28","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.4049\/jimmunol.162.9.5389","article-title":"Peptide recognition by two HLA-A2\/Tax11-19-specific T cell clones in relationship to their MHC\/peptide\/TCR crystal structures","volume":"162","author":"Hausmann","year":"1999","journal-title":"J Immunol"},{"key":"2022061701372049500_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.193.5.551","article-title":"Identification of a crucial energetic footprint on the \u03b11 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide\/HLA-A2-specific T cell receptors","volume":"193","author":"Baker","year":"2001","journal-title":"J Exp Med"},{"key":"2022061701372049500_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1349-7006.2009.01453.x","article-title":"Biased usage of BV gene families of T cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies","volume":"101","author":"Tanaka-Harada","year":"2010","journal-title":"Cancer Sci"},{"key":"2022061701372049500_bib31","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1128\/JVI.73.8.6436-6443.1999","article-title":"Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax","volume":"73","author":"Koya","year":"1999","journal-title":"J Virol"},{"key":"2022061701372049500_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L","article-title":"Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity","volume":"37","author":"Aubry","year":"1999","journal-title":"Cytometry"},{"key":"2022061701372049500_bib33","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/JVI.02013-07","article-title":"Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells","volume":"82","author":"Baba","year":"2008","journal-title":"J Virol"},{"key":"2022061701372049500_bib34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"},{"key":"2022061701372049500_bib35","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1128\/JVI.02212-07","article-title":"Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells","volume":"82","author":"Daucher","year":"2008","journal-title":"J Virol"},{"key":"2022061701372049500_bib36","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.0900069","article-title":"The avidity and lytic efficiency of the CTL response to HTLV-1","volume":"182","author":"Kattan","year":"2009","journal-title":"J Immunol"},{"key":"2022061701372049500_bib37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","article-title":"CTL quality and the control of human retroviral infections","volume":"39","author":"Bangham","year":"2009","journal-title":"Eur J Immunol"},{"key":"2022061701372049500_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coi.2005.03.002","article-title":"Human tumor-specific T lymphocytes: does function matter more than number?","volume":"17","author":"Coulie","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"2022061701372049500_bib39","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.4049\/jimmunol.173.12.7622","article-title":"Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma","volume":"173","author":"Zhou","year":"2004","journal-title":"J Immunol"},{"key":"2022061701372049500_bib40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/clim.2000.4890","article-title":"Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture","volume":"96","author":"thor Straten","year":"2000","journal-title":"Clin Immunol"},{"key":"2022061701372049500_bib41","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AEM.64.10.3724-3730.1998","article-title":"Bias in template-to-product ratios in multitemplate PCR","volume":"64","author":"Polz","year":"1998","journal-title":"Appl Environ Microbiol"},{"key":"2022061701372049500_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00251-002-0508-y","article-title":"Examination of the highly diverse CD4(+) T-cell repertoire directed against an influenza peptide: a step towards TCR proteomics","volume":"54","author":"Cameron","year":"2002","journal-title":"Immunogenetics"},{"key":"2022061701372049500_bib43","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20051357","article-title":"Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses","volume":"202","author":"Price","year":"2005","journal-title":"J Exp Med"},{"key":"2022061701372049500_bib44","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2004-10-4045","article-title":"Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia","volume":"106","author":"Wlodarski","year":"2005","journal-title":"Blood"},{"key":"2022061701372049500_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.exphem.2003.11.011","article-title":"Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis","volume":"32","author":"Plasilova","year":"2004","journal-title":"Exp Hematol"},{"key":"2022061701372049500_bib46","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1098\/rsbl.2003.0088","article-title":"Analysis of \u2018driver\u2019 and \u2018passenger\u2019 CD8+ T-cell responses against variable viruses","volume":"271","author":"Zafiropoulos","year":"2004","journal-title":"Proc Biol Sci"},{"key":"2022061701372049500_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2007.09.006","article-title":"How does HTLV-I persist despite a strong cell-mediated immune response?","volume":"29","author":"Asquith","year":"2008","journal-title":"Trends Immunol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/15\/6181\/2636553\/6181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/15\/6181\/2636553\/6181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T06:32:10Z","timestamp":1685687530000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/15\/6181\/559518\/Single-Cell-Analysis-of-T-Cell-Receptor-Repertoire"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":47,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2010,7,28]]},"published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-0678","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,28]]}}}